Enhertu 100 mg powder for concentrate for solution for infusion *

  • Company:

    Daiichi Sankyo Ireland Ltd
  • Status:

    No Recent Update
  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)
  • Active Ingredient(s):

    This medicinal product is subject to additional monitoring.

    *Additional information is available within the SPC or upon request to the company

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 17 June 2021

File name

PIL-Enhertu-V01-(IB shelf life ext + editorial)-300421_1623936641.pdf

Reasons for updating

  • New PIL for new product

Free text change information supplied by the pharmaceutical company

Type IB Shelf-life extension & editorial updates

EDM Updated on 17 June 2021

File name

DSE_ENHERTU_Patient_Card-ILD_IE_V1-200421_1623936457.pdf

Reasons for updating

  • Add New Doc

Free text change information supplied by the pharmaceutical company

V00 - MA grant & HPRA approved

EDM Updated on 17 June 2021

File name

DSE_ENHERTU_HCP_Guide-ILD_IE_V1-200421_1623936457.pdf

Reasons for updating

  • Add New Doc

Free text change information supplied by the pharmaceutical company

V00 - MA grant & HPRA approved

EDM Updated on 17 June 2021

File name

DSE_ENHERTU_HCP_Guide_PoPCME_IE_V1-200421_1623936457.pdf

Reasons for updating

  • Add New Doc

Free text change information supplied by the pharmaceutical company

V00 - MA grant & HPRA approved

Updated on 17 June 2021

File name

SmPC-Enhertu-V01-(IB shelf life ext + editorial)-300421_1623936178.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

Type IB shelf life extension & editorial updates